The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai Germany; Falk Pharma; Incyte
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Eisai Germany; Ipsen; Roche
Prediction of early treatment failure of second-line nal-iri/5-FU/FA in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216).
 
Meinolf Karthaus
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen
 
Nikolaus Ansorge
No Relationships to Disclose
 
Gleb Barmashenko
No Relationships to Disclose
 
Christof Burkart
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim
 
Thomas Decker
Consulting or Advisory Role - Novartis
 
Thomas Jens Ettrich
Consulting or Advisory Role - AstraZeneca; Bayer; BMS GmbH & Co. KG; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; Eisai; Incyte; Ipsen; Lilly; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen
 
Anke Gerhardt
Honoraria - Janssen
Consulting or Advisory Role - Incyte; Janssen; Novartis; Shire
 
Sabine Hoefling
No Relationships to Disclose
 
Lutz Jacobasch
No Relationships to Disclose
 
Michael Koenigsmann
No Relationships to Disclose
 
Sebastian Räth
No Relationships to Disclose
 
Markos Schulte
No Relationships to Disclose
 
Nadine Schulte
No Relationships to Disclose
 
Andreas Schwarzer
No Relationships to Disclose
 
Gabriele Margareta Siegler
Honoraria - Aurikamed; Deutsche Röntgengesellschaft; Eisai; Janssen-Cilag; Roche
Consulting or Advisory Role - AstraZeneca; Janssen-Cilag
Research Funding - Novartis (Inst); Nutricia (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen
 
Dirk Waldschmidt
No Relationships to Disclose
 
Manfred P. Lutz
Research Funding - SERVIER (Inst)